Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Retinoblastoma 22Unspecified Adult Solid Tumor, Protocol Specific 5Sarcoma 4Medulloblastoma 4Central Nervous System Neoplasms 4Rhabdoid Tumor 3Retinal Neoplasms 3Optic Nerve Glioma 3Neuroblastoma 3Carcinoma, Renal Cell 3Astrocytoma 3Wilms Tumor 2Relapsed Pediatric Solid Tumor 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Melanoma 2Hepatoblastoma 2Familial ependymoma 2Extensive Stage Small Cell Lung Cancer 2Choroid Plexus Neoplasms 2Advanced Solid Tumors 2Uveal Melanoma 1Urologic Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unresectable Locally Advanced or Metastatic Solid Tumors 1Thyroid Neoplasms 1Thrombocytopenia 1Testicular Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1

Interventions

Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy 1Etoposide 1Drug Therapy 1Cyclophosphamide 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pharyngeal Neoplasms × Etoposide × Other solid neoplasm × Clear all
NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡